Subcutaneous allergen immunotherapy in 3 patients with HIV

Annals of Allergy, Asthma and Immunology

Volumn 105, Issue 4, 2010, Pages 320-321

  Fodeman, Jason ^a   Jariwala, Sunit ^a   Hudes, Golda ^a   Jerschow, Elina ^a   Rosenstreich, David ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; DESLORATADINE; EFAVIRENZ; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN E; IMMUNOLOGIC AGENT; MOMETASONE FUROATE; RAGWEED ANTIGEN; RECOMBINANT ALLERGEN; STAVUDINE; TENOFOVIR;

ABSENCE OF SIDE EFFECTS; ADULT; ALLERGEN IMMUNOTHERAPY; ALLERGIC RHINITIS; CASE REPORT; CD4 LYMPHOCYTE COUNT; CHRONIC ALLERGIC RHINOSINUSITIS; COCKROACH; DOG; DRUG INDICATION; FEMALE; GRASS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; LETTER; MAINTENANCE THERAPY; MALE; MOULD; NASAL PRURITUS; OCULAR PRURITUS; PRIORITY JOURNAL; RHINOSINUSITIS; SKIN TEST; SNEEZING; TREATMENT DURATION; TREE; VIRUS LOAD;

ADULT; ALLERGENS; CD4 LYMPHOCYTE COUNT; CHRONIC DISEASE; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HIV; HIV INFECTIONS; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; RISK ASSESSMENT; SINUSITIS; SNEEZING; VIRAL LOAD;

EID: 77957890655     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2010.06.017     Document Type: Letter

References (11)

1. M. Corominas, J.F. Garcia, M. Mestre, P. Fernndez-Viladrich, and E. Buendia Predictors of atopy in HIV-infected patients Ann Allergy Asthma Immunol 84 2000 607 611
2. C.B. Small, A. Kaufman, M. Armenaka, and D.L. Rosenstreich Sinusitis and atopy in human immunodeficiency virus infection J Infect Dis 167 1993 283 290
3. M. Clerici, and G.M. Shearer A TH1→TH2 switch is a critical step in the etiology of HIV infection Immunol Today 14 1993 107 111
4. S. Yerly, W. Wunderli, and C.A. Wyler Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral load AIDS 8 1994 1503 1504
5. M. Keller, A. Deveikis, and M. Cutillar-Garcia Pneumococcal and influenza immunization and human immunodeficiency virus load in children Pediatr Infect Dis J 19 2000 613 618
6. H. Aladdin, H. Ullum, and S. Dam Nielsen Granulocyte colony-stimulating factor increases CD4+ T cell counts of human immunodeficiency virus-infected patients receiving stable, highly active antiretroviral therapy: results from a randomized, placebo-controlled trial J Infect Dis 181 2000 1148 1152
7. G. Skowron, D. Stein, and G. Drusano The safety and efficacy of granulocyte-macrophage colony-stimulating factor (Sargramostim) added to indinavir- or ritonavir-based antiretroviral therapy: a randomized double-blind, placebo-controlled trial J Infect Dis 180 1999 1064 1071
8. S. Emery, W.B. Capra, and D.A. Cooper Pooled analysis of 3 randomized, controlled trials of interleukin-2 therapy in adult human immunodeficiency virus type 1 disease J Infect Dis 182 2000 428 434
9. I.S. Randhawa, I. Junaid, and W.B. Klaustermeyer Allergen immunotherapy in a patient with human immunodeficiency virus: effect on T-cell activation and viral replication Ann Allergy Asthma Immunol 98 2007 495 497
10. M.A. Ostrowski, S.K. Stanley, J.S. Justement, K. Gantt, D. Goletti, and A.S. Fauci Increased in vitro tetanus-induced production of HIV type 1 following in vivo immunization of HIV type 1-infected individuals with tetanus toxoid AIDS Res Hum Retroviruses 13 1997 473 480
11. K.R. Fowke, R. D'Amico, and D.N. Chernoff Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients AIDS 11 1997 1013 1021